maximal Valsalva. The diagnosis of levator avulsion was based on tomographic ultrasound imaging (TUI) on volumes obtained at pelvic floor muscle contraction. Using TUI, a set of eight slices was obtained at 2.5-mm intervals, from 5 mm below to 12.5 mm above the plane of minimal hiatal dimensions. Results: We analysed a total of 117 patients. Pelvic hiatal area obtained at rest in patients before 8th week of gestation was 13.22±2.20 cm 2 and postpartum 14.52±2.64 cm 2 . Hiatal area contraction obtained in patients before 8th week of gestation was 11.59±2.01 cm 2 and postpartum 12.53±2.76 cm 2 . Hiatal area obtained in Valsalva in patients prior to week 8th of gestation was 15.31±2.85 cm 2 and postpartum 17.85±5.42 cm 2 . These differences in area measurements were statistically significant in all cases. The levator ani muscle avulsion was observed in 23(19.6%) patients, 16 (13.6%) bilateral and 7 (5.9%) unilateral lesions. In these cases, the increase of the hiatus area in valsalva is statistically significant. Conclusions: Transperineal 3DUS can assess the anatomical changes that occur to the pelvic floor in relation to pregnancy and childbirth. The follow-up and assessment of the evolution of the hiatus area and levator ani muscle avulsion, would allow the classification of patients at risk of prolapse in the future.
P07.10
Transperineal 3D pelvic ultrasound in the assessment of complex voiding dysfunction following failed suburethral sling division surgery Results: Of 12 patients with persisting symptoms post sling division, 9 had 2 slings in situ and 2 had pubovaginal fascial sling. All had undergone previous transvaginal surgery to relieve obstruction (8 had division of sling,4 had excision of a suburethral sling segment). Dynamic compression of the urethra by sling was observed on 2D imaging in all patients. 10 of 12 patients had overangulation/distortion of urethral axis due to the obstructive sling (8 synthetic, 2 fascial), 3 of whom were demonstrated only when scanned in sitting position. 3D volume analysis showed 2 patients had sling erosion into urethra and 2 had vaginal erosion. In 3 patients who had undergone excision of a suburethral sling segment, 3D volume analysis showed there was incomplete excision with a small amount of sling continuity. 10 patients subsequently underwent urethrolysis with excision of a suburethal sling segment and resolution of voiding dysfunction. Conclusions: Transperineal 3D Ultrasound has a useful role in the assessment of complex patients with persistent voiding dysfunction post sling division, especially in those with multiple slings in situ. Our findings suggest that incision of an obstructive sling may not adequately relief obstruction and excision of a sub-urethral portion of sling may be preferable. Objectives The aim of the study was to compare the cerebroplacental ratio (CPR) in fetuses with different estimated weight. Methods This retrospective study included 600 pregnant women, between 34 and 41 weeks of g.a. All cases have been divided into 4 groups according to the estimated fetal weight (EFW) centile. Groups 1 and 2 included small-for-gestational-age fetuses: group 1 with EFW < 3‰ (n=12); group 2 with EFW 3-10 ‰ (n=34). Group 3 included appropriate-for-gestational-age fetuses (AGA) with EFW 10-90 ‰ (n=534) and group 4 included large--for-gestational-age fetuses (LGA) with EFW > 90 ‰ (n=20). Doppler measurements of the umbilical artery and MCA pulsatility indexes were used to calculate cerebroplacental ratio (CPR). Student's t-test for independent variables was applied to compare these parameters which followed the normal distribution.
Results: CPR was equal 1,71 in group 1, 1.93 in group 2, 1.97 in group 3 and 2.14 in group 4. The statistically significant difference was revealed between group 1 of small-for-gestational-age fetuses with EFW < 3‰ and group 4 of large-for-gestational-age fetuses with EFW above 90 centile only (p=0.048). There were no statistically significant differences between two other groups 2 and 3 (p > 0.05).
Conclusions:
Cerebroplacental ratio is lower in SGA-fetuses and higher in LGA-fetuses, but may have no differences with AGA-fetuses.
P08.02
The correlation between parental biometric parameters and neonatal head circumference: a prospective study R. Abushqara, L. Daoud Sabag, M. Safrai, L. Matan, S. Porat
Obstetrics and Gynecology, Hadassah-Hebrew University Medical Centres, Jerusalem, Israel
Objectives: Abnormal fetal head circumference (FHC) during pregnancy may indicate a pathologic process of fetal brain development. We aimed to elucidate the correlation between parental and demographic factors with neonatal head circumference (NHC) in our population. Methods: This prospective study was conducted between 6/2015 and 3/2017. Inclusion criteria included singletons, born at 37-42 weeks' gestation, with availability of both biologic parents to participate. Exclusion criteria were IUGR neonates, cases with large caput, cephalhematoma or subgaleal hematoma, maternal diabetes and neonatal congenital anatomical or genetic abnormalities. Parental head circumference, weight and height were measured. Other data including NHC were obtained from the medical record. All head circumference measurements were transformed to percentiles. Results: 185 trios of mothers, fathers and neonates were recruited for the study. Maternal head circumference (MHC) was found to be positively correlated with NHC (p=0.001). This correlation remained significant when sub-analysed for males (p=0.036) and for females (p=0.013). In addition neonatal gender, maternal height, weight before pregnancy and weight at term were also significantly correlated with NHC (p-values 0.014, 0.004, 0.03, 0.01 respectively). In a multivariate analysis, MHC and neonatal gender were the only significant independent predictors. However the model could explain only 8.6% of the NHC variability. Conclusions: NHC is influenced by maternal body habitus and neonatal gender. The low R 2 of the prediction model implies that head growth during fetal life is influenced by other factors.
Paternal body habitus and head circumference did not significantly affect neonatal head circumference. This result makes sense from an evolutionary perspective. This means that big males who may be attractive by females do not influence the fetal/neonatal head circumference, and thereby do not influence on the chances of successful vaginal delivery of their offspring.
P08.03
Low-dose aspirin for prevention of fetal growth restriction and pre-eclampsia in twins: the GAP pilot randomised trial Objectives: To estimate the impact of low-dose aspirin started in the first trimester in twin pregnancies. Methods: We performed a randomised trial of women with twins between 10 and 14 weeks of gestation. They were randomised to 81 mg of aspirin at bedtime or an equivalent placebo from randomisation (<14 weeks) until 36 weeks'. Primary outcome was the birthweight of live infants. Secondary outcomes include very low birth weight (VLBW) neonates (<1500 grams); pre-eclampsia; and aspirin non-responsiveness defined by a normal platelet aggregation test (PFA-100<145). We aimed to recruit 50 participants (100 fetuses) to have the power to detect a difference of 400 grams between the groups based on a previous meta-analysis. Results: Fifty participants were randomised at a mean gestational age of 13.0±0.6 weeks and complete follow-up was obtained for all. We observed 2 cases of PE in women in the aspirin group and no case in the placebo group (p=0.49). Forty-seven newborns alive in the aspirin group were compared to 48 newborns alive in the placebo group: no significant difference were observed for our primary outcome (aspirin: 2385±529 grams vs placebo: 2224±706 grams, p=0.21) and VLBW (6% vs 15%, p=0.20). Of note, 16/25 (65%) of the participants in the aspirin group had a normal PFA-100, including the two cases of pre-eclampsia and the additional case of gestational hypertension. Conclusions: We observed no significant impact of 81 mg of aspirin started in the first trimester on birthweight, VLBW and pre-eclampsia. However, the majority of women with twin pregnancies were ''non-responsive'' to aspirin at 81 mg daily according to the platelet aggregation test. Subsequent trials evaluating the impact of aspirin on twin pregnancies should use more than 81 mg of aspirin.
